Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 3/20 | 0.77 |
| ▸ | EDNRB | P24530 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CCR9 | P51686 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7008931 | 0.90 | EDNRA (0.74) | EDNRAEDNRBKMT2AMEN1KDM4E | |
| SCHEMBL7009309 | 0.90 | EDNRA (0.76) | EDNRAEDNRBKMT2AMEN1KDM4E | |
| SCHEMBL7006427 | 0.90 | EDNRA (0.81) | EDNRAEDNRBKMT2AMEN1KDM4E | |
| SCHEMBL9157048 | 0.86 | EDNRA (0.73) | EDNRAEDNRBKMT2AMEN1KDM4E | |
| SCHEMBL7013111 | 0.86 | EDNRA (0.80) | EDNRAEDNRBKMT2AMEN1 | |
| SCHEMBL9152177 | 0.85 | EDNRA (0.72) | EDNRAEDNRBKMT2AMEN1KDM4E | |
| SCHEMBL7006905 | 0.83 | EDNRA (0.70) | EDNRAEDNRBKMT2AMEN1CCR9 | |
| SCHEMBL7006902 | 0.83 | EDNRA (0.70) | EDNRAEDNRBKMT2AMEN1CCR9 | |
| SCHEMBL7008278 | 0.83 | EDNRA (0.70) | EDNRAEDNRBKMT2AMEN1CCR9 | |
| SCHEMBL7099111 | 0.82 | EDNRA (0.63) | EDNRAEDNRBKMT2AMEN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0601386-B1 | Sulphonamides | HOFFMANN LA ROCHE (CH) | 2003-02-05 | — | — | EP | claimed |
| US-5420129-A | Treatment of hypertension, ischemia, vasospasms, angina | HOFFMANN-LA ROCHE INC. (US) | 1995-05-30 | — | — | US | claimed |
| EP-0601386-A1 | Sulphonamides | F. HOFFMANN-LA ROCHE AG (CH) | 1994-06-15 | — | — | EP | claimed |
| EP-0601386-B1 | Sulphonamides | HOFFMANN LA ROCHE (CH) | 2003-02-05 | — | — | EP | disclosed |
| WO-2001049289-A1 | PHARMACEUTICAL AND VETERINARY USES OF ENDOTHELIN ANTAGONISTS | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2001-07-12 | — | — | WO | disclosed |
| US-5420129-A | Treatment of hypertension, ischemia, vasospasms, angina | HOFFMANN-LA ROCHE INC. (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0601386-A1 | Sulphonamides | F. HOFFMANN-LA ROCHE AG (CH) | 1994-06-15 | — | — | EP | disclosed |